Ampersand buys Peptides International, merges it with New England Peptide
Ampersand Capital Partners has acquired Peptides International and merged it with portfolio company New England Peptide.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
